T. Rowe Price Associates »

Eledon Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $155k 50k 3.09
2025-12-31 $45k 30k 1.53
2025-09-30 $77k 30k 2.61
2025-06-30 $80k 30k 2.71

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Geode Capital Management
Catalio Capital Management
Zimmer Partners
Sphera Funds Management
State Street Corporation
AWM Investment Company
UBS Group
Kingdon Capital Management
Millennium Management

View all funds holding Eledon Pharmaceuticals